Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III crossover study of inhaled fluticasone propionate on short-term growth and HPA-axis function in pre-pubertal children with mild asthma
2007-000130-39Phase 3Completed
- Sponsor
- Neolab Ltd
- Start
- Jan 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Flixocort in asthma (2 arms), sponsored by Neolab Ltd. Primary endpoints: Short-term linear growth velocity and HPA-axis function. Started Jan 2007; status: completed.
02
Drugs
Flixocort
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-000130-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000130-39.